Try our Advanced Search for more refined results
Life Sciences - November, 2010
155 articles
- Doctor Indicted Over False Fen-Phen Injury Claims
- Novartis Wins OK On $175M Deal To End Bias Action
- AIDS Nonprofit Says BMS Overcharged For Drugs
- J&J Units Target Impax Over Generic Concerta
- AMAG Updates Feraheme Label To Include Safety Risks
- Insurer's Bid To Recoup $15M Sprint D&O Payout Nixed
- Allergan, AMD, Bosch Face False Marking Suits
- Alzheimer's Group Hits UPenn, Avid With Patent Suit
- J&J Must Pay Basilea $130M Over License: Dutch Court
- Cardinal Health Buys Chinese Drug Importer For $470M
- New EU Rule Eases Biosimilar Development
- The Continuing Struggle For D&O Coverage
- Syntrix Slaps Illumina With Biotech Patent Suit
- Coventry Wins Partial Toss Of Copay Class Action
- Federal Circ. Fleshes Out Prosecution Laches
- Nev. High Court Affirms $58M Award Against Wyeth
- Novartis Hit With $1M Ruling In Aredia, Zometa Suit
- J&J Recalls 9M Tylenol Meds Over Missing Alcohol Label
- FDA Crime Head To Depart Amid Misconduct Claims
- Sonova Recalls Cochlear Implants Made By US Unit
- Genzyme, Daiichi Sankyo Fight More Welchol ANDAs
- Judge Won't Rehear Dismissal Bid In Wyeth Pristiq Suit
- 7th Circ. Pins Down Atty Fee Awards In Lanham Case
- J&J Pulls Children's Benadryl, Motrin Off Shelves
- Philly Judge Nixes GSK Paxil Birth Defect Suit
- Pharma Struggles To Escape FCPA Net
- Implant Maker Seeks To Subpoena Dickstein In IP Spat
- Attorneys Brace For Surge In Sex Bias Class Actions
- Wyeth Appeals Retaliation Trial Order To High Court
- Amgen Loses Bid To Wrap Up Teva Patent Fight
- FCA Settlements Top $3B In FY2010
- Life Tech Sues GenMark Over DNA Test Patent
- Avandia Plaintiffs Must Comply With Lone Pine Order: Judge
- Merck Picks Up Another Win In Fosamax Bellwether
- Darvon Maker Pulls Painkiller From US Market
- W.Va. High Court Nixes $4.5M Verdict Against J&J Unit
- Bristol-Myers Hit With False Marking Suit Over 3 Drugs
- CIBC Continues To Dog Attys In Chem Rx Ch. 11
- Merck Unit Sues TriGen Over Folic Acid Patents
- Class Attys Score $38M Fee In Novartis Sex Bias Suit
- EU Drug Agency OKs Rule On Biosimilar Antibodies
- Vioxx Plaintiffs Take $5B Deal Woes To High Court
- King Investors Fail To Speed Suit Over $3.6B Pfizer Sale
- Jones Day Lures Biotech IP Partners From McDermott
- Bristol-Myers Sales Rep Sues For Overtime Pay
- Ropes Gray Reps Genzyme In $265M Diagnostics Sale
- France Says Diabetes Drug May Have Led To 500 Deaths
- Smith & Nephew Loses 2nd Bid To Kill FCA Dispute
- Siga Says Survey Will Bolster Bid For $2.8B Contract
- Wachtell Reps Cardinal Health In $1.3B Kinray Buy
- Upsher-Smith Faces False Marking Suit Over Diet Drug
- 2nd Circ. Remands State Claims In Pfizer Firing Suit
- The Challenges Of FDA's Nascent Biosimilars Regime
- Ameritox To Pay $16M To Resolve Medicaid FCA Suit
- Rituxan Wrongful Death Suit Stays In Federal Court
- Greenberg Adds Veteran Senate Atty To Health Group
- $3M Bail Set For Doctor Accused Of Tipping Off Fund
- Stanford Appeal Reignites IP Custody Battle
- Ex-Baseball Player Gets 9 Years For Medicare Fraud
- FDA Accused Of Contempt In Plan B Availability Case
- Settlement Funds Established In Avandia MDL
- Stryker Can't Nix USPTO Ruling In Bone Screw IP Row
- Lilly Chemotherapy Drug Patent Valid, Judge Rules
- Merck, Schering-Plough Hit With False Marking Suit
- Judge Clears Path For Generic Dr. Reddy's Asthma Drug
- CIBC Fights Fox Rothschild Fees In Chem Rx Ch. 11
- Healthfirst Hands Over $7.7M In Marketing Rep OT Suit
- FDA Seeks To Improve Safety Of Heart Defibrillators
- Otsuka Triumphs In Abilify Patent Litigation
- Pay-For-Delay Is Smart And Legal, Drugmakers Argue
- Hospira Sues Caraco To Block Generic Precedex
- Flonase Purchasers Win Class Cert. In Suit Against GSK
- Medicare Fraud Units Will Scrutinize Health Care Cos.
- Doctor Preps Bail Package In Hedge Fund Tip-Off Case
- Utah Slaps GSK With Medicaid Fraud Suit Over Avandia
- BASF Dodges Claims From Vitamin Cartel Victims
- Smith & Nephew Asks Court To Rethink FCA Ruling
- US Reversal Frames Issues In Myriad's Appeal
- GSK Atty Indictment May Paralyze Lawyers
- FDA Releases Raw Heparin Shipments To Amphastar
- Convicted Pharma Fraudster Seeks Post-Trial Acquittal
- Teva, Others Settle With Counties In Medicaid MDL
- Hawaii Sues McKesson For Allegedly Inflating AWPs
- AstraZeneca Hits Watson With Crestor Patent Suit
- Pfizer Fights Whistleblower Retaliation Suit In 2nd Circ.
- Fed. Circ. Revives Merck Suit Over Temodar Patent
- Cobalt's Generic Boniva Barred In Roche IP Spat
- Mylan Reaches $2.6M Deal In Mass. Medicaid Case
- Stanley Black & Decker Hit With False Marking Suit
- Fed. Circ. Nixes Abraxis Win In Naropin Patent Row
- Feds Hit Back At Stryker Biotech's Dismissal Bids
- DC Circ. Upholds Exclusivity For ADHD Drug Vyvanse
- Abbott, Others Argue For New Inequitable Conduct Rule
- Omnicare Investors Drop High Court Appeal
- Ex-GSK Atty Indicted For Obstructing Federal Probe
- Class Action Alleges Dexatrim Contains Carcinogen
- FDA Warns Claris Over Contaminated Drugs
- FDA Got Too Close To Drug Firms: GAO
- House Leaders To Probe FDA's Puerto Rico Office
- Navy Defends Decision To Nix $15M Drug Test Deal
- Q&A With Dechert's Sean Wajert
- FDA Blames GE, Toshiba Radiation Problems On Misuse
- Wyeth Effexor Patent Valid, Infringed: Australian Judge
- Novo Nordisk, Actavis End PrandiMet Patent Spat
- DOJ Ends Reagents Antitrust Probe Into Immucor
- The Trend Toward Using The Risk-Utility Test
- AAI Urges FTC To Reconsider CVS Caremark Merger
- Edwards Lifesciences Subpoenaed Over Heart Monitor
- Centocor Loses Bid To Dismiss Remicade Suit
- Inequitable Conduct Doctrine Takes Stage In Fed. Circ.
- Siga Appeals $2.8B Drug-Contract Disqualification
- Whistleblowers Seek To Revive Suit Against Medco
- Q&A With Dinsmore & Shohl's James Zeszutek
- Weil Gotshal Advises Lilly In $800M Avid Deal
- Ex-Bristol Myers Worker Pleads Guilty To IP Theft
- Dendreon Inks $17M Deal In Shareholder Action
- FDA Falls Short On Medical Device Monitoring: Report
- Q&A With Cahill's Bart Friedman
- Akzo, AstraZeneca Face 'Dead Peasant' Policy Suit
- Pharmacy's Provigil Action To Remain In Federal Court
- Astellas Targets Glenmark Over Eczema Drug
- Smith & Nephew Fails To Shake Whistleblower Suit
- Class Can't Kill Plaintiffs Atty's AWP Ban Appeal
- Oracle Ex-Pres. Says Bilked Software Worth Billions
- KV Securities Plaintiffs Fight Denial Of Bid To Amend
- Ex-Biggest Loser Ends Spat With Another Diet Co.
- The Government Stance On Generic Preemption
- Valeant Settles Biovail Frivolous Suit Claims For $10M
- Judge Squashes Hostess Trans Fat Labeling Suit
- Allergan's Bid For New Trial Rejected In Zymar Case
- MDL Judge Wants More Info On Zicam Settlement
- Q&A With Kelley Drye's Julian Solotorovsky
- Genzyme Sues Lupin Over Generic Welchol
- Watson Reaches Deal With J&J For Concerta Generic
- 5th Circ. Revives Cardinal Health Qui Tam Suit
- Fosamax Judge Restricts Bellwether Trial Evidence
- Thermo Fisher Hit With Patent Suit Over Lab Device
- DOJ's Policy Shift Could Change Future Of DNA IP
- Chem Rx's $70M Sale To PharMerica Gets Green Light
- FDA Starts On Path To Approving Biosimilars
- French Doctor Busted For Allegedly Selling Inside Tips
- Mylan Drops Appeal In Generic Paxil Contract Fight
- CareFusion Antitrust Claims Nixed In Medtronic Suit
- Oracle, SAP Face Off Over Infringement Damages
- Fed. Circ. Denies Lilly En Banc Review In Gemzar Feud
- FDA Issues Class I Recall Of Medtronic's Octopus Nuvo
- Fed. Circ. Upholds Injunction On Generic Pulmicort
- Skadden Reps McKesson In $2B US Oncology Deal
- Supreme Court Disbars Former Fen-Phen Torts Atty
- Pfizer Recalls 38,000 More Bottles Of Lipitor
- Fresenius Goes After Lupin Over PhosLo ANDA
- DOJ Urges Compromise In Gene Patent Appeal Brief
- High Court To Weigh Rights In Gov't-Funded Inventions
- Thoughts On Say-On-Pay Frequency
- Increasing Scrutiny Of Gov't Contingent Fee Deals